Cytokine modulation correlates strongly with symptom improvement in patients with myelofibrosis treated with nuvisertib (TP-3654), an investigational selective PIM1 kinase inhibitor Meeting Abstract
| Authors: | Rein, L. A. M.; El Chaer, F.; Yuda, J.; Shimoda, K.; Rampal, R.; Scandura, J. M.; Takami, A.; McCloskey, J.; Ichii, M.; Shirane, S.; Iurlo, A.; Bose, P.; Lucchesi, A.; Benevolo, G.; Amanam, I.; Vachhani, P.; Tantravahi, S. K.; Rotta, M.; Onishi, Y.; Kiladjian, J. J.; Rinaldi, C.; Granacher, N.; Bradley, T.; Patel, A. A.; Loschi, M.; Alimam, S.; Cheung, S.; Ribrag, V.; Kabir, S.; Seki, M.; Pharmd, K. A.; Guffanti, G.; Lee, J.; Warner, S. L.; Foulks, J. M.; Mesa, R. |
| Abstract Title: | Cytokine modulation correlates strongly with symptom improvement in patients with myelofibrosis treated with nuvisertib (TP-3654), an investigational selective PIM1 kinase inhibitor |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 3180 |
| End Page: | 3181 |
| Language: | English |
| ACCESSION: | WOS:001412581600035 |
| DOI: | 10.1182/blood-2024-200999 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
